Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Mesothelioma, Malignant × Radiofrequency Ablation × 1 year × Clear all

Sponsor

Conditions

Thyroid Nodule 4 Thyroid Neoplasms 3 Pain 2 Agnosia 2 Thyroid Cancer, Papillary 1 Prostatic Neoplasms 1 Neuroma 1 Neuralgia 1 Neoplasm Metastasis 1 Myoma 1 Multiple Advanced Tumors After PD-1 Therapy Failure 1 Multi-organ Metastatic Colorectal Cancer 1 Menorrhagia 1 Lymphatic Metastasis 1 Leiomyoma 1 Klatskin Tumor 1 Hypesthesia 1 Hyperthyroidism 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Medullary 1 Breast Neoplasms 1 Breast Cancer Female 1 Bile Duct Neoplasms 1 Barrett Esophagus 1 Adenoma, Islet Cell 1 Adenocarcinoma Of Esophagus 1 Adenocarcinoma 1

Interventions

Cisplatin 15 Pemetrexed 12 pembrolizumab 8 Nivolumab 8 Carboplatin 7 Ipilimumab 5 Cyclophosphamide 5 Platinum 4 1,2-diaminocyclohexaneplatinum II citrate 4 Gemcitabine 3 Drug Therapy 3 tremelimumab 2 fludarabine 2 durvalumab 2 atezolizumab 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Radiation 2 Photochemotherapy 2 Methotrexate 2 Interleukin-2 2 Chemotherapy, Adjuvant 2 sargramostim 1 olaparib 1 niraparib 1 nintedanib 1 methoxyamine 1 lenvatinib 1 enzalutamide 1 decitabine and cedazuridine drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡